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HR (95% CI) p value1Adjusted
HR(95% CI) p valueTotal population
(n¼927)
n¼809 n¼118Cardiac death 35 (4.3) 5 (4.2) 1.02 (0.40-
2.61)0.96 0.57 (0.20-
1.62)0.29All-cause death 76 (9.4) 14 (11.9) 1.30 (0.73-
2.29)0.37 0.95 (0.52-
1.73)0.86Spontaneous MI 3 (0.4) 3 (2.5) 7.14 (1.44-
35.38)0.02 4.76 (0.95-
23.97)0.06Cardiac death
or MI35 (4.3) 7 (5.9) 1.45 (0.64-
3.27)0.37 0.90 (0.37-
2.15)0.81CVA 40 (4.9) 6 (5.1) 1.08 (0.46-
2.54)0.87 0.63 (0.25-
1.60)0.33Repeat
revascularization69 (8.5) 7 (5.9) 0.73 (0.33-
1.58)0.42 0.62 (0.27-
1.44)0.26MACCE 158 (19.5) 26 (22.0) 1.19 (0.78-
1.80)0.42 0.97 (0.63-
1.49)0.88Data are presented as n (%).
CI ¼ conﬁdence interval; CVA ¼ cerebrovascular accident; HR ¼ hazard ratio; LVEF ¼ left ventricular ejection
fraction; MI ¼ myocardial infarction; MACCE ¼ major adverse cardiac and cerebrovascular event; PMI ¼ peri-
procedural MI 1Adjusted covariates include LVEF (%), bridge collaterals, and multivessel disease.
CONCLUSIONS PMI may not be associated with increased cardiac
mortality after coronary revascularization in patients with stable CTO.
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BACKGROUND The ability of the SYNTAX score (SS) for long-term
outcomes after newer-generation drug eluting stents (DES) have not
been fully investigated. The aim of this study was to investigate the
ability of the SS for long-term outcomes of patients treated with
newer-generation DES.
METHODS The SS was collected consecutive 2247 patients treated
with only newer-generation DES. Post hoc analysis was performed by
stratifying clinical outcomes at 3-year follow-up, according to one of
three SS tertiles. Tertiles for SS were deﬁned as low-SS < 8 (n¼734),
8  mid-SS  15 (n¼681), high-SS >15 (n¼832).
RESULTS Clinical follow-up information at 3-year was obtained
98.4%. At 3-year, the rate of major adverse cardiac event (MACE),
deﬁned as cardiac death, myocardial infarction (MI), and clinically-
driven target lesion revascularization (CD-TLR), was 8.8 % vs.12.3 %
vs. 17.8 % in the three SS groups, respectively (p<0.001). Similarly,
CD-TLR (6.1 % vs. 7.9 % vs. 13.5 %, p<0.001), MI (0.9 % vs. 2.7 % vs.
2.8%, p¼0.03) and cardiac death (2.9 % vs. 3.7 % vs. 5.4 %, p¼0.02)
were increased signiﬁcantly with increasing SS tertile. The SS inde-
pendently predicted 3-year MACE in multivariate analysis (hazard
ratio 1.05, 95 % conﬁdence interval 1.02-1.09; p¼0.001).CONCLUSIONS The SS was applicable to unrestricted use of newer-
generation DES in predicting the risk of long-term outcomes. The SS is
a useful angiographic predictive tool after newer-generation DES.
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BACKGROUND Coronary artery bypass grafting (CABG) has long been
the preferred revascularization approach in patients with left main
(LM) disease. However, evolving percutaneous coronary intervention
(PCI) techniques with DES implantation have shown comparable
short-term efﬁcacy and safety during the last decade. Concurrently,
ACC/AHA guidelines have made a Class IIa recommendation for PCI in
patients with LM stenosis and favorable anatomy. However, concerns
persist regarding long-term prognosis of PCI with DES in high risk LM
disease. Therefore, we aimed to investigate the cumulative evidence
for long-term outcomes of PCI with DES versus CABG in patients with
LM stenosis
METHODS A systematic review of randomized control trials and
observational studies in MEDLINE, EMBASE, EBSCO, CINAHL, Web of
Science and Cochrane databases comparing PCI with DES to CABG for
LM disease was performed. Only studies with a median follow-up of at
least 4 years were included. Pre-speciﬁed outcomes of interest were
all-cause mortality, cardiovascular mortality, myocardial infarction
(MI), stroke, and repeat revascularization. Random-effects meta-an-
alyses were performed, using risk ratios as the metric of choice.
RESULTS Nine studies comprising two RCTs and seven observational
studies, with a total of 6156 patients were included. Median duration
of follow-up was 56 months. Overall, there were no signiﬁcant dif-
ferences between PCI with DES and CABG in terms of all-cause mor-
tality [RR 0.81, 95% CI 0.63-1.04; I2¼66.8%] and cardiovascular
mortality [RR 0.92, 95% CI 0.54-1.58; I2¼72.1%]. Compared with
CABG, PCI was associated with a signiﬁcant increase in the risk of MI
[RR 1.59, 95% CI 1.07-2.36; I2¼38.2%] and repeat revascularization [RR
2.68, 95% CI 1.98-3.62; I2¼70%]. Whereas, a numerically lower risk of
stroke with PCI as compared to CABG [RR 0.59, 95% CI 0.31-1.13;
I2¼51.3%] was observed. The results were consistent between RCTs
and observational studies for each outcome.
